Proud to call New Jersey home
Johnson & Johnson was the first innovative healthcare company to be founded in New Jersey. 138 years later we remain an innovation powerhouse, advancing healthcare in the Garden State—and around the globe.
Through scientific innovation and technology, Johnson & Johnson is tackling the world’s toughest health challenges. Last year, we spent $15 billion on research & development, with significant investment in New Jersey.
Our state-of-the-art manufacturing and research facilities are developing next-generation treatments, including multiple myeloma cancer therapies and cutting-edge antibacterial surgical sutures, right here in the state of New Jersey.
We take pride in calling New Jersey home—a state renowned for its rich diversity, top ranking education system, and focus on STEM education.
Our state-of-the-art manufacturing and research facilities are developing next-generation treatments, including multiple myeloma cancer therapies and cutting-edge antibacterial surgical sutures, right here in the state of New Jersey.
We take pride in calling New Jersey home—a state renowned for its rich diversity, top ranking education system, and focus on STEM education.
Johnson & Johnson has a 138-year history in our home state of New Jersey. We are proud to have helped make our state a global innovation powerhouse.
Joaquin Duato
Chairman and CEO
What’s new in NJ
J&J by the numbers
$15 billion
Invested in research & development across Innovative Medicine and MedTech globally
33
The number of J&J clinical trials currently underway in New Jersey
#1
Ranked #1 in the Pharmaceutical Category on the Fortune World’s Most Admired Companies list for the 10th year in a row in February 2023
At work in New Jersey
Meet a nurse who leads clinical trials to find innovative cancer therapies
Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.
“I’ve developed innovative sutures that help save lives”
Johnson & Johnson got its start as a pioneer of sterile surgical sutures and continues to make advancements today. Jesse Nawrocki, Ph.D., shares how he and his award-winning team are working to make surgery easier for doctors and safer for patients.
Learn about 3 health advocates who gather in NJ every year for empowerment and connection
In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
History spotlight
Illustration of the first Johnson & Johnson building in New Brunswick, New Jersey in 1886.
Image courtesy: Johnson & Johnson Archives
The roots of Johnson & Johnson’s modern Innovative Medicines business begin in 1940 with the establishment of a pharmaceutical manufacturing facility in Linden, New Jersey.
Johnson & Johnson put the first mass produced sterile surgical dressings and sutures on the market in 1886 and 1887 to help make surgery survivable for patients.
Image courtesy: © Andrew McCaul Photography
Ethicon sutures manufactured in Somerville, New Jersey were used in the first successful human to human heart transplant in Cape Town, South Africa in 1967.
Image courtesy: © Andrew McCaul Photography
Johnson Hall Clock Tower
The lighting of the Johnson Hall Clock Tower in New Brunswick is used to raise awareness of important global health-related observances and noteworthy anniversaries.
October highlights:
World Sight Day
Clock tower lighting: Blue
Date: October 11th
Johnson & Johnson Reaches 50 Million Children Through Sight For Kids Program
World Arthritis Day
Clock tower lighting: Blue
Date: October 12th
Rheumatoid, psoriatic and osteoarthritis—what you need to know about the 3 main types of arthritis
